Pfizer turned to Jarvik because Lipitor, the world's best-selling drug, is losing market share to a generic version of a competing cholesterol drug, Zocor, ...
Global sales fell 2 percent to $12.7 billion in 2007, hurt by competition from low-cost generic forms of Merck & Co Inc's Zocor. ...
It settled allegations that the company failed to pay rebates due to the Medicaid program on the sale of the drugs Zocor, Vioxx and Pepcid. ...
Simcor combines Abbott's Niaspan, a pill that raises HDL, the so-called good cholesterol, with generic Zocor, also known as simvastatin, a drug in a class ...
s Zocor, came on the market in 2006. Sales of Lipitor fell 1.6 percent last year. ``Obviously they have taken some criticism and heat on that Jarvik ad ...
The settlement resolves allegations Merck shortchanged rebates paid to the Medicaid program for Zocor and Vioxx. The total settlement came to $8.7 million, ...
The ENHANCE trial found that high cholesterol patients did no better taking Vytorin over the generic form of Zocor and that patients on Vytorin actually had ...
That means that if your LDL is very high to start with, you might still have to take a cholesterol-lowering drug such as Zocor, even if you eat oats. ...
It is alleged that Schering-Plough misled investors regarding the increased efficacy of Vytorin, a combination of Zetia and Zocor, over the cheaper generic ...
The settlement resolves allegations Merck shortchanged rebates paid to the Medicaid program for Zocor and Vioxx. The total settlement came to $8.7 million, ...